Third Proxy Firm Favors Re-election of Illumina Board Members over Roche Candidates | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A third proxy advisory firm has recommended that Illumina shareholders re-elect all four members of its board who up for re-election at the firm's annual shareholders meeting next week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.